The Genomes.io gene data market has sparked controversy over alleged racial discriminatory pricing. Critics claim the platform's pricing model disproportionately charges higher fees for genetic data from underrepresented racial groups, raising ethical concerns about fairness and access in genomic research. Genomes.io denies these allegations, asserting that pricing reflects data rarity and research value, not race. However, the lack of transparency in their pricing algorithm has fueled skepticism, with advocates arguing it could exacerbate existing disparities in genomic medicine. The debate highlights broader issues of equity in the growing gene data market, prompting calls for stricter regulations to prevent exploitation and ensure fair access to genetic testing for all communities, particularly marginalized ones.